Pipeline / Status / Phase I

Incidence
Targeted Indication
Product Information
OreniPro™ (once-daily, oral treprostinil prodrug)
RemoPro™ (treprostinil prodrug)
Unexisome™ (exosomes)
LNG01 (Wnt inhibitor)